Upgrade to SI Premium - Free Trial

SAB Biotherapeutics (SABS) PT Lowered to $7 at H.C. Wainwright

March 11, 2026 6:57 AM
(Updated - March 11, 2026 6:58 AM EDT)

H.C. Wainwright analyst Emily Bodnar lowered the price target on SAB ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change